HomeLatest

Latest

Talimogene Laherparepvec in HER2-Negative Breast Cancer: A Phase Ib Study

A new clinical study at the National Cancer Institute in the U.S. is looking into a treatment method for patients with a specific type...

New Strategies and Tech in Lymphedema Prevention Following Breast Cancer

Developing effective strategies for preventing breast cancer-related arm lymphedema (BCRAL) remains a significant unmet need in healthcare, as there are currently no effective treatments...

Tumor Cell ‘Homing’ and the Mastectomy vs. Lumpectomy Debate

Notable breast surgeon and researcher, Dr. Kefah Mokbel, is advocating the benefits of breast-conserving therapy over mastectomy in certain patients, based on a combination...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is...

ERα-dicating the Core of Breast Cancer Resistance

Scientists have made an important breakthrough in understanding a key player in most breast cancers. At The Institute of Cancer Research in London, a...

Hot Topics